| First Author | Gerlach BD | Year | 2021 |
| Journal | Cell Metab | Volume | 33 |
| Issue | 12 | Pages | 2445-2463.e8 |
| PubMed ID | 34784501 | Mgi Jnum | J:321718 |
| Mgi Id | MGI:6875512 | Doi | 10.1016/j.cmet.2021.10.015 |
| Citation | Gerlach BD, et al. (2021) Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metab 33(12):2445-2463.e8 |
| abstractText | Apoptotic cell clearance by macrophages (efferocytosis) promotes resolution signaling pathways, which can be triggered by molecules derived from the phagolysosomal degradation of apoptotic cells. We show here that nucleotides derived from the hydrolysis of apoptotic cell DNA by phagolysosomal DNase2a activate a DNA-PKcs-mTORC2/Rictor pathway that increases Myc to promote non-inflammatory macrophage proliferation. Efferocytosis-induced proliferation expands the pool of resolving macrophages in vitro and in mice, including zymosan-induced peritonitis, dexamethasone-induced thymocyte apoptosis, and atherosclerosis regression. In the dexamethasone-thymus model, hematopoietic Rictor deletion blocked efferocytosing macrophage proliferation, apoptotic cell clearance, and tissue resolution. In atherosclerosis regression, silencing macrophage Rictor or DNase2a blocked efferocyte proliferation, apoptotic cell clearance, and plaque stabilization. In view of previous work showing that other types of apoptotic cell cargo can promote resolution in individual efferocytosing macrophages, the findings here suggest that signaling-triggered apoptotic cell-derived nucleotides can amplify this benefit by increasing the number of these macrophages. |
